Filing Flows › Comparisons › XENE vs PRAX
Xenon Pharmaceuticals vs Praxis Precision Medicines: XENE and PRAX compared
Xenon Pharmaceuticals is the larger company: $7.5M of revenue in its latest quarter (Q1 2025) against $7.5M for Praxis Precision Medicines (Q4 2024). Praxis Precision Medicines is more profitable, with an operating margin of -857.0% against -969.8%.
Where the money goes: XENE and PRAX
Xenon Pharmaceuticals (XENE) · Q1 2025
Xenon Pharmaceuticals, Q1 2025: revenue $7.5M, operating margin -969.8%, net loss $65.0M, operating cash flow −$61.7M. The chart follows the revenue to costs, profit and cash.
Praxis Precision Medicines (PRAX) · Q4 2024
Praxis Precision Medicines, Q4 2024: revenue $7.5M (14× year over year), operating margin -857.0%, net loss $58.7M, operating cash flow −$56.1M. The chart follows the revenue to costs, profit and cash.
| Xenon Pharmaceuticals (XENE) | Praxis Precision Medicines (PRAX) | |
|---|---|---|
| Latest quarter | Q1 2025 | Q4 2024 |
| Revenue | $7.5M | $7.5M |
| Revenue growth, Y/Y | — | 14× |
| Operating margin | -969.8% | -857.0% |
| Net earnings | −$65.0M | −$58.7M |
| Net margin | -867.3% | -786.3% |
| Operating cash flow | −$61.7M | −$56.1M |
| Market value | $3.6B | $8.3B |
| Analysts’ mean target | $71.75 | $650.00 |
Questions
Which is bigger, Xenon Pharmaceuticals or Praxis Precision Medicines?
Xenon Pharmaceuticals is the larger company: $7.5M of revenue in its latest quarter (Q1 2025) against $7.5M for Praxis Precision Medicines (Q4 2024).
Is Xenon Pharmaceuticals or Praxis Precision Medicines growing faster?
Praxis Precision Medicines is more profitable, with an operating margin of -857.0% against -969.8%.
More: Xenon Pharmaceuticals earnings · how Xenon Pharmaceuticals makes money · Praxis Precision Medicines earnings · how Praxis Precision Medicines makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 12, 2025; 10-K filed Feb 28, 2025). Fiscal quarters can end on different dates. Not investment advice.